NEA Management Company, LLC — 13F holdings

NEA Management Company, LLC reported 26 holdings worth $1.59B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. TRVI Trevi Therapeutics Inc — $247M (15.5%)
2. MBX MBX BIOSCIENCES INC — $200M (12.6%)
3. GLUE MONTE ROSA THERAPEUTICS INC — $186M (11.7%)
4. CELC CELCUITY INC — $179M (11.3%)
5. SGP SPYGLASS PHARMA INC — $165M (10.4%)
6. SVRA SAVARA INC — $151M (9.5%)
7. ZBIO ZENAS BIOPHARMA INC — $102M (6.4%)
8. COUR COURSERA INC — $72.6M (4.6%)
9. AUPH AURINIA PHARMACEUTICALS INC — $67.4M (4.2%)
10. CRSP CRISPR Therapeutics AG — $57.7M (3.6%)